Teladoc Health (NYSE:TDOC) Shares Down 5% - Here's Why

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report)'s share price traded down 5% during trading on Wednesday . The stock traded as low as $12.27 and last traded at $12.39. 4,408,114 shares traded hands during mid-day trading, a decline of 22% from the average session volume of 5,644,407 shares. The stock had previously closed at $13.04.

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. Oppenheimer cut their price target on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a report on Friday, January 24th. Royal Bank of Canada upped their price target on Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a report on Friday, January 24th. The Goldman Sachs Group began coverage on Teladoc Health in a report on Friday, November 15th. They issued a "buy" rating and a $14.00 price target for the company. Deutsche Bank Aktiengesellschaft upped their price objective on Teladoc Health from $10.00 to $12.00 and gave the company a "hold" rating in a research note on Friday, November 1st. Finally, Barclays upped their price objective on Teladoc Health from $10.00 to $12.00 and gave the company an "overweight" rating in a research note on Thursday, October 31st. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $12.08.

Teladoc Health Stock Performance

The firm has a fifty day simple moving average of $10.28 and a 200-day simple moving average of $9.28. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The stock has a market cap of $2.47 billion, a price-to-earnings ratio of -2.49 and a beta of 1.05.

Insiders Place Their Bets

In other news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the transaction, the insider now owns 2,890 shares of the company's stock, valued at $34,477.70. This represents a 45.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.95% of the company's stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Whipplewood Advisors LLC acquired a new position in shares of Teladoc Health in the 4th quarter valued at $29,000. Versant Capital Management Inc lifted its stake in shares of Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after purchasing an additional 2,441 shares during the period. Lindbrook Capital LLC lifted its stake in shares of Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after purchasing an additional 1,612 shares during the period. Blue Trust Inc. lifted its stake in shares of Teladoc Health by 84.5% in the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider's stock valued at $40,000 after purchasing an additional 1,854 shares during the period. Finally, Sterling Capital Management LLC lifted its stake in shares of Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after purchasing an additional 4,101 shares during the period. Institutional investors and hedge funds own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.